A Nomogram Model to Predict Early Recurrence of Patients With Intrahepatic Cholangiocarcinoma for Adjuvant Chemotherapy Guidance: A Multi-Institutional Analysis
Qi Li(First Affiliated Hospital of Xi'an Jiaotong University), Zhaohui Tang(Shanxi Agricultural University), Yinghe Qiu(Second Military Medical University), Yu He(Southern University of Science and Technology), Tianqiang Song(Tianjin Medical University Cancer Institute and Hospital), Xianhai Mao(Hunan Provincial People's Hospital), Zhangjun Cheng(Zhongda Hospital Southeast University), Dong Zhang(Capital Medical University), Jian Zhang(Zhujiang Hospital), Jingdong Li(Sun Yat-sen University), Hong Wu(Shanghai Tenth People's Hospital), Zhimin Geng(Children's Hospital of Zhejiang University), Chen Chen(First Affiliated Hospital of Xi'an Jiaotong University), Wenlong Zhai(Zhengzhou University)
Cited by 17
Related Papers
NF-κB in biology and targeted therapy: new insights and translational implications
|Signal Transduction and Targeted Therapy|2024|1.6k
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652